Login to Your Account



PharmaFocus

Valeant Pharmaceuticals Picks Up OraPharma for $426M

By Catherine Shaffer
Staff Writer

Monday, June 18, 2012
Valeant Pharmaceuticals Inc. continued its specialty pharma shopping spree with an agreement to acquire oral health firm OraPharma Inc. for $312 million with up to $114 million in additional milestones.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription